RecruitingNCT07160023

Local Registry of Primary Cutaneous T-cell Lymphomas


Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Enrollment

600 participants

Start Date

Oct 12, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This registry aims to collect retrospective and prospective data on patients with primary cutaneous T-cell lymphoma who are treated at the Dermatology Clinic of the IRCCS Policlinico San Matteo Foundation.


Eligibility

Min Age: 6 Years

Plain Language Summary

Simplified for easier understanding

This is a local registry study — not a treatment trial — for people diagnosed with primary cutaneous T-cell lymphoma (CTCL), a type of cancer that begins in the skin's immune cells. Researchers are collecting real-world data on how this rare condition is diagnosed and managed in clinical practice. **You may be eligible if...** - You have a diagnosis of primary cutaneous T-cell lymphoma - You are receiving care at the Dermatology Unit in Pavia, Italy **You may NOT be eligible if...** - You are not a patient at the listed dermatology clinic Talk to your dermatologist to see if this registry is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

SC Dermatologia, Fondazione IRCCS Policlinico San Matteo

Pavia, Pavia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07160023